Εμφάνιση απλής εγγραφής

dc.creatorSowa M., Kolenda R., Baumgart D.C., Pratschke J., Papp M., Tornai T., Suchanski J., Bogdanos D.P., Mytilinaiou M.G., Hammermann J., Laass M.W., Conrad K., Schramm C., Franke A., Roggenbuck D., Schierack P.en
dc.date.accessioned2023-01-31T09:59:41Z
dc.date.available2023-01-31T09:59:41Z
dc.date.issued2018
dc.identifier10.3389/fimmu.2018.01959
dc.identifier.issn16643224
dc.identifier.urihttp://hdl.handle.net/11615/79238
dc.description.abstractIntroduction: Zymogen granule glycoprotein 2 (GP2) was demonstrated as first autoimmune mucosal target in primary sclerosing cholangitis (PSC) associated with disease severity. Autoantibodies to four GP2 isoforms (aGP21−4) were found in patients with inflammatory bowel diseases but reactivity against specific GP2 epitopes has not been investigated in PSC yet. Hence, the prevalence of aGP21−4 and their association with the PSC phenotype for risk prediction were examined. Methods: GP2 isoforms were stably expressed as glycosylphosphatidyl - inositol-anchored molecules in the membrane of HEp-2 cells and used as autoantigenic targets in indirect immunofluorescence assay (IFA). aGP21−4 IgA and IgG were detected by IFA in 212 PSC patients of four European university hospitals and 145 controls comprising 95 patients with cystic fibrosis and 50 healthy subjects. Results: Combined aGP21 and aGP24 IgA testing with a sensitivity of 66.0% and a specificity of 97.9% resulted in the best diagnostic performance (Youden index: 0.64) regarding all aGP2 and combinations thereof. aGP24 IgA positivity is significantly associated with the presence of cirrhosis in PSC (p = 0.0056). Logistic regression revealed the occurrence of aGP21 IgA (odds ratio [OR] 1.38, 95% confidence interval [CI]: 1.03–1.86) and aGP24 IgA (OR 1.52, 95%CI: 1.07–2.15) along with male gender (OR 0.51, 95%CI: 0.27–0.97) and older age (OR 1.03 95%CI: 1.01–1.05) as significant risks for the concomitant presence of cirrhosis in PSC. Conclusions: Combined aGP21 and aGP24 IgA analysis is preferred to single aGP2 isoform analysis for sensitive PSC autoantibody testing. Positivity for aGP21 and aGP24 IgA is associated with cirrhosis in PSC and could be used for risk stratification. © Copyright © 2018 Sowa, Kolenda, Baumgart, Pratschke, Papp, Tornai, Suchanski, Bogdanos, Mytilinaiou, Hammermann, Laass, Conrad, Schramm, Franke, Roggenbuck and Schierack.en
dc.language.isoenen
dc.sourceFrontiers in Immunologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85068120394&doi=10.3389%2ffimmu.2018.01959&partnerID=40&md5=68e47547465e82b06a8ac1676918dd52
dc.subjectautoantibodyen
dc.subjectbiological markeren
dc.subjectglycosylphosphatidylinositol anchored proteinen
dc.subjectGP2 protein, humanen
dc.subjectisoproteinen
dc.subjectadulten
dc.subjectageden
dc.subjectautoimmunityen
dc.subjectclinical trialen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectimmunologyen
dc.subjectindirect fluorescent antibody techniqueen
dc.subjectliver cirrhosisen
dc.subjectmaleen
dc.subjectmiddle ageden
dc.subjectmucosal immunityen
dc.subjectmulticenter studyen
dc.subjectpathologyen
dc.subjectsclerosing cholangitisen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAutoantibodiesen
dc.subjectAutoimmunityen
dc.subjectBiomarkersen
dc.subjectCholangitis, Sclerosingen
dc.subjectFemaleen
dc.subjectFluorescent Antibody Technique, Indirecten
dc.subjectGPI-Linked Proteinsen
dc.subjectHumansen
dc.subjectImmunity, Mucosalen
dc.subjectLiver Cirrhosisen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectProtein Isoformsen
dc.subjectFrontiers Media S.A.en
dc.titleMucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotypeen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής